1-9 of 9
David L. Caudell, DVM
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Poison Oligonucleotide F10 Is Efficiently Taken Up By, and Highly Effective Against, Acute Lymphoblastic Leukemia While Sparing Normal Hematopoietic Cells

Timothy Pardee, MD, PhD, Jamie Jennings-Gee, PhD, Kristin Stadelman, MS, David L. Caudell, DVM, PhD, William Gmeiner, PhD
Journal: Blood
Blood (2013) 122 (21): 2674.
https://doi.org/10.1182/blood.V122.21.2674.2674
Published: 2013
Journal Articles

A NUP98-HOXD13 Leukemic Fusion Gene Leads To Aberrant Actin Localization In Dysplastic Megakaryocytes

David L. Caudell, DVM, PhD, Benjamin Okyere, PhD, Jacob Cawley, Abdul Gafoor A. Puthiyaveetil, DVM, PhD, Bettina Heid
Journal: Blood
Blood (2013) 122 (21): 2486.
https://doi.org/10.1182/blood.V122.21.2486.2486
Published: 2013
Journal Articles

The Novel Ribonucleotide Reductase Inhibitor Didox Is Active Against AML with Limited Toxicities

Guerry J Cook, MSc, David L. Caudell, DVM, PhD, Howard L Elford, PhD, Timothy Pardee, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1513.
https://doi.org/10.1182/blood.V120.21.1513.1513
Published: 2012
Journal Articles

The Leukemic Fusion Gene NUP98-HOXD13 Suppresses Non-Homologous End Joining Factors and Impairs DNA Double Strand Break Repair

David L. Caudell, DVM, PhD, Abdul Gafoor A. Puthiyaveetil, DVM
Journal: Blood
Blood (2012) 120 (21): 521.
https://doi.org/10.1182/blood.V120.21.521.521
Published: 2012
Journal Articles

Unique Dual Targeting of Thymidylate Synthase and Topoisomerase1 by FdUMP[10] Results in High Efficacy Against AML and Low Toxicity

Timothy Pardee, MD, PhD, Evan Gomes, PhD, Jamie Jennings-Gee, PhD, David L. Caudell, DVM, PhD, William Gmeiner, PhD
Journal: Blood
Blood (2011) 118 (21): 2584.
https://doi.org/10.1182/blood.V118.21.2584.2584
Published: 2011
Journal Articles

A NUP98-HOXD13 Fusion Gene Impairs B Lymphocyte Development and Function In a Mouse Model for Myelodysplastic Syndrome

Abdul Gafoor A. Puthiyaveetil, DVM, Bettina Heid, David L. Caudell, DVM, PhD
Journal: Blood
Blood (2010) 116 (21): 279.
https://doi.org/10.1182/blood.V116.21.279.279
Published: 2010
Journal Articles

The Novel Fluoropyrimidine FdUMP[10] Is Highly Active Against Acute Myeloid Leukemia

Timothy Pardee, MD, PhD, Evan Gomes, PhD, Jamie Jennings-Gee, PhD, David L. Caudell, DVM, PhD, William Gmeiner, PhD
Journal: Blood
Blood (2010) 116 (21): 3302.
https://doi.org/10.1182/blood.V116.21.3302.3302
Published: 2010
Journal Articles

Use of CALM-AF10 and NUP98-HOXD13 fusions to Identify Oncogenic Pathways That Collaborate with HOXA9 Overexpression

Rachel L Novak, PhD, David P Harper, MD, David L. Caudell, DVM, PhD, Sarah H Beachy, PhD, Yang Jo Chung, PhD, Linda Wolff, PhD, Peter Aplan, MD
Journal: Blood
Blood (2010) 116 (21): 2499.
https://doi.org/10.1182/blood.V116.21.2499.2499
Published: 2010
Journal Articles

The CALM-AF10 Fusion Gene Expressed in Transgenic Mice Produces Acute Leukemia.

David L. Caudell, DVM, Zhenhau Zhang, Yangjo Chung, Ph.D., Peter D. Aplan, MD
Journal: Blood
Blood (2006) 108 (11): 358.
https://doi.org/10.1182/blood.V108.11.358.358
Published: 2006